, 2022-09-14 19:08:52,
Embark, a canine DNA testing company founded in 2015 by brothers Ryan and Adam Bokyo in Cornell’s Incubator for Life Science Companies, is now taking strides in studies of the canine genome. With the swab of a dog’s cheek, Embark can provide information about the dog’s genetic risk factors and ancestry.
Embark is working on building a data set of cutting edge genetic information of dogs for research purposes, while simultaneously helping dog owners accumulate as much knowledge about their dog’s health as possible.
“Our message is that we can help owners take the best care of their dog with preventable issues that could come up and help owners maximize the time and quality of time they get to spend with their dog,” said founder and Chief Executive Officer Ryan Boyko.
Embark has made landmark discoveries in the field of canine genetics such as inbreeding depression in golden retrievers, blue eye coloration in huskies and hearing loss in rhodesian ridgebacks.
“We are not comfortable with the status quo of the 250 things we can test for today,” co-founder of Embark Prof. Adam Boyko, biomedical sciences said “We want to find the next 250 things so that DNA testing is even more valuable in the future.”
Embark is pushing boundaries in canine genetics by working with researchers to create new tests to further learn about each dog’s ancestry.
To read the original article from news.google.com, Click here